Difference between revisions of "PDFF Biomarker Ctte"
Jump to navigation
Jump to search
(43 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
− | == | + | |
+ | :Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD | ||
+ | :RSNA Staff Support: Susan Stanfa | ||
+ | * [https://docs.google.com/spreadsheets/d/e/2PACX-1vQZBtnrVMpQOU8BEKlY_4hs21JQoEhq_926-HCFtPm77AHzJ3-dp_S6cedeDfbIIILljxJVongZMJsb/pubhtml?gid=1460430101&single=true Roster] | ||
+ | |||
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF. | The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF. | ||
− | ==Meetings | + | |
− | *[[PDFF Biomarker Committee Call Summaries]] | + | ==Meetings== |
+ | |||
+ | '''Approved call summaries:''' | ||
+ | <br />Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on April 1, 2021. | ||
+ | |||
+ | *[[Media:2021_02-04_QIBA_PDFF_BC_Call_Summary-FINAL.pdf|February 4, 2021]] | ||
+ | *[[Media:2021_01-07_QIBA_PDFF_BC_Call_Summary-FINAL.pdf|January 7, 2021]] | ||
+ | *[[Media:2020_11-05_QIBA_PDFF_BC_Call_Summary-FINAL.pdf|November 5, 2020]] | ||
+ | |||
+ | '''''[[PDFF Biomarker Committee Call Summaries Archive]]''''' | ||
==Working Documents== | ==Working Documents== |
Revision as of 18:52, 22 November 2021
- Co-chairs: Scott Reeder, MD, PhD, Takeshi Yokoo, MD, PhD
- RSNA Staff Support: Susan Stanfa
The PDFF Biomarker Committee seeks to develop a quantitative Profile for PDFF.
Meetings
Approved call summaries:
Notes are posted after they are approved by the PDFF BC during the following t-con. The last meeting was on April 1, 2021.
PDFF Biomarker Committee Call Summaries Archive